Innovita Biological Technology Co., Ltd.

SHSE:688253 Stock Report

Market Cap: CN¥5.6b

Innovita Biological Technology Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Xiujie Zhang

Chief executive officer

CN¥1.4m

Total compensation

CEO salary percentagen/a
CEO tenure4yrs
CEO ownership9.2%
Management average tenureno data
Board average tenure4yrs

Recent management updates

Recent updates

We Think Innovita Biological Technology's (SHSE:688253) Robust Earnings Are Conservative

Nov 01
We Think Innovita Biological Technology's (SHSE:688253) Robust Earnings Are Conservative

Investors Could Be Concerned With Innovita Biological Technology's (SHSE:688253) Returns On Capital

Sep 28
Investors Could Be Concerned With Innovita Biological Technology's (SHSE:688253) Returns On Capital

Statutory Profit Doesn't Reflect How Good Innovita Biological Technology's (SHSE:688253) Earnings Are

Apr 22
Statutory Profit Doesn't Reflect How Good Innovita Biological Technology's (SHSE:688253) Earnings Are

There's Reason For Concern Over Innovita Biological Technology Co., Ltd.'s (SHSE:688253) Massive 25% Price Jump

Mar 20
There's Reason For Concern Over Innovita Biological Technology Co., Ltd.'s (SHSE:688253) Massive 25% Price Jump

CEO

Xiujie Zhang (53 yo)

4yrs

Tenure

CN¥1,360,600

Compensation

Ms. Xiujie Zhang serves as Director and General Manager at Innovita Biological Technology Co., Ltd. since November 9, 2020.


Board Members

NamePositionTenureCompensationOwnership
Xiujie Zhang
GM & Director4yrsCN¥1.36m9.19%
CN¥ 519.0m
Yi Lin
Director4yrsCN¥10.00kno data
Jian Sun
Independent Director4yrsCN¥86.70kno data
Guanmu Dong
Independent Director4yrsCN¥86.70kno data
Tian long Hu
Independent Director4yrsCN¥86.70kno data
Fengguang Ye
Chairman of the Board4yrsCN¥294.40k27.84%
CN¥ 1.6b

4.0yrs

Average Tenure

50yo

Average Age

Experienced Board: 688253's board of directors are considered experienced (4 years average tenure).